Arrowgrass Capital Partners (US)’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-125,000
Closed -$18.3M 205
2017
Q4
$18.3M Buy
125,000
+123,750
+9,900% +$17.6M 0.18% 141
2017
Q3
$17M Sell
1,250
-366
-23% -$46.2K 0.13% 199
2017
Q2
$20.2M Hold
1,616
0.15% 181
2017
Q1
$19.2M Buy
1,616
+482
+43% +$58K 0.2% 146
2016
Q4
$13.1M Sell
1,134
-1,749
-61% -$195K 0.15% 144
2016
Q3
$30.1M Buy
2,883
+652
+29% +$68.1K 0.4% 60
2016
Q2
$21.7M Buy
+2,231
New +$211K 0.23% 70

Other funds holding CME

Arrowgrass Capital Partners (US)'s CME Position: Q1 2018 in Review

Arrowgrass Capital Partners (US) sold out of CME Group (CME) in Q1 2018, closing a stake of 866 shares — an estimated $126K sold.

Arrowgrass Capital Partners (US) first reported a position in CME in Q2 2016 and held it in 7 quarters. The position peaked at $4.1M in Q2 2016. 898 funds tracked by Wall St. Rank hold CME as of Q1 2018.

  • Arrowgrass Capital Partners (US) reported no remaining CME Group position as of Q1 2018 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 866 CME Group shares in Q1 2018, an estimated $126K.
  • Arrowgrass Capital Partners (US) first reported a position in CME Group in Q2 2016 and held it in 7 quarters.
  • Arrowgrass Capital Partners (US)'s CME Group position peaked at $4.1M in Q2 2016.
  • 898 funds tracked by Wall St. Rank held CME Group as of Q1 2018.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q1 2018, filed 15 May 2018.